Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CureLink AB
AB
Active
Org 5592170194
Esplanaden 15 B, 234 39
Lomma
Temporary employment agency activities and other human resource provisions
·
NACE 7820
Est. 2019 · 6 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Temporary employment agency activities and other human resource provisions
/
CureLink AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
56M
42M
28M
14M
0M
20M
2021
27M
+35%
2022
30M
+11%
2023
34M
+13%
2024
45M
+32%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
20 044
27 126
30 446
34 105
45 079
Staff expenses
—
—
—
—
−3 017
EBITDA
1 227
1 034
1 211
745
901
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
1 227
1 034
1 211
745
901
Net financials
−2
−2
−4
8
5
Profit before tax
1 226
1 032
1 207
753
906
Tax
−258
−223
−260
−165
−195
Net profit
968
809
947
588
710
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
4 787
5 757
6 812
8 749
7 607
Equity
1 255
1 704
1 851
1 689
1 899
Long-term debt
400
400
220
220
220
Short-term debt
3 133
3 653
4 741
6 840
5 488
Total debt
3 533
4 053
4 961
7 060
5 708
Financial ratios
5-year trend
EBITDA margin
2.0%
This company
15.8%
Market median
87% below market
2021
2025
Equity ratio
25.0%
This company
38.2%
Market median
35% below market
2021
2025
Return on equity
37.4%
This company
18.4%
Market median
103% above market
2021
2025
Net profit margin
1.6%
This company
8.1%
Market median
80% below market
2021
2025
Asset turnover
5.93×
This company
1.12×
Market median
429% above market
2021
2025
Debt / equity
3.01×
This company
0.62×
Market median
385% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CureLink AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
